These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21401790)

  • 1. Eligibility and rate of treatment for recombinant tissue plasminogen activator in acute ischemic stroke using different criteria.
    Huang P; Khor GT; Chen CH; Lin RT; Liu CK
    Acad Emerg Med; 2011 Mar; 18(3):273-8. PubMed ID: 21401790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: way to endeavor.
    Huang P; Chen CH; Yang YH; Lin RT; Lin FC; Liu CK
    Cerebrovasc Dis; 2006; 22(5-6):423-8. PubMed ID: 16912476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute stroke management in the elderly.
    Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
    Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study.
    Kleindorfer D; Kissela B; Schneider A; Woo D; Khoury J; Miller R; Alwell K; Gebel J; Szaflarski J; Pancioli A; Jauch E; Moomaw C; Shukla R; Broderick JP;
    Stroke; 2004 Feb; 35(2):e27-9. PubMed ID: 14739423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telephonic guidance of systemic thrombolysis in acute ischemic stroke: safety outcome in rural hospitals.
    Vaishnav AG; Pettigrew LC; Ryan S
    Clin Neurol Neurosurg; 2008 May; 110(5):451-4. PubMed ID: 18353532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of tissue plasminogen activator for acute ischemic stroke in a rural Wisconsin hospital.
    Charipar R; Charipar E
    WMJ; 2008 Jul; 107(4):176-80. PubMed ID: 18702433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study.
    Kwiatkowski T; Libman R; Tilley BC; Lewandowski C; Grotta JC; Lyden P; Levine SR; Brott T;
    Ann Emerg Med; 2005 Apr; 45(4):377-84. PubMed ID: 15795715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary acute ischemic stroke therapy with intravenous recombinant tissue plasminogen activator.
    Frank JI
    Clin Neurosurg; 2000; 46():261-6. PubMed ID: 10944682
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke.
    Cocho D; Belvís R; Martí-Fàbregas J; Molina-Porcel L; Díaz-Manera J; Aleu A; Pagonabarraga J; García-Bargo D; Mauri A; Martí-Vilalta JL
    Neurology; 2005 Feb; 64(4):719-20. PubMed ID: 15728300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacist Impact on Ischemic Stroke Care in the Emergency Department.
    Gosser RA; Arndt RF; Schaafsma K; Dang CH
    J Emerg Med; 2016 Jan; 50(1):187-93. PubMed ID: 26412104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why are eligible thrombolysis candidates left untreated?
    Hills NK; Johnston SC
    Am J Prev Med; 2006 Dec; 31(6 Suppl 2):S210-6. PubMed ID: 17178305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of intravenous recombinant tissue plasminogen activator in acute ischemic stroke.
    Kahn JH; Viereck J; Kase C; Jeerakathil T; Romero R; Mehta SD; Kociol R; Babikian V
    J Emerg Med; 2005 Oct; 29(3):273-7. PubMed ID: 16183445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue plasminogen activator use in a patient with acute ischemic stroke coexisting with meningioma.
    Hsieh HC; Chen CH
    Clin Neurol Neurosurg; 2009 Jul; 111(6):562-3. PubMed ID: 19200644
    [No Abstract]   [Full Text] [Related]  

  • 15. Local intra-arterial thrombolysis with urokinase for acute ischemic stroke before and after the approval of intravenous tissue plasminogen activator treatment in Taiwan.
    Yang FC; Lin CC; Hsueh CJ; Lee JT; Hsu CH; Lee KW; Peng GS
    Ann Vasc Surg; 2010 Nov; 24(8):1117-24. PubMed ID: 21035704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and outcome of patients with early complete neurological recovery after thrombolysis for acute ischemic stroke.
    Blinzler C; Breuer L; Huttner HB; Schellinger PD; Schwab S; Köhrmann M
    Cerebrovasc Dis; 2011; 31(2):185-90. PubMed ID: 21160181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do women benefit more from systemic thrombolysis in acute ischemic stroke? A Serbian experience with thrombolysis in ischemic stroke (SETIS) study.
    Jovanović DR; Beslać-Bumbasirević Lj; Budimkić M; Pekmezović T; Zivković M; Kostić VS;
    Clin Neurol Neurosurg; 2009 Nov; 111(9):729-32. PubMed ID: 19647928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of Thai patients with acute ischemic stroke after intravenous thrombolysis.
    Dharmasaroja PA; Dharmasaroja P; Muengtaweepongsa S
    J Neurol Sci; 2011 Jan; 300(1-2):74-7. PubMed ID: 20937509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid neurological recovery after intravenous tissue plasminogen activator in stroke: prognostic factors and outcome.
    Machumpurath B; Davis SM; Yan B
    Cerebrovasc Dis; 2011; 31(3):278-83. PubMed ID: 21178353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicine. Stroke--tPA and the clinic.
    Marler JR; Goldstein LB
    Science; 2003 Sep; 301(5640):1677. PubMed ID: 14500967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.